Internal Medicine
RSSArticles
-
Spironolactone for Heart Failure
-
The CORAL Trial: Is This the End for Renal Artery Stenting?
-
TAVR in the Real World: The Initial 18 months' Experience in the United States
-
Safety of Eplerenone in Heart Failure Patients
-
Infectious Disease Malpractice: The $1.2 Million Miscommunication
-
Two-step Screening for Ovarian Cancer: A ‘Scissor-step’ Forward?
-
Improving Adherence: Who's Doing the Work?
Approximately 50% of patients with chronic illnesses do not adhere to indicated medications, treatment regimens, and healthy lifestyle changes.
-
Efficacy of Higher-dose Oseltamivir in Adults with Influenza A and B
In a prospective, open-label, intervention study conducted over four influenza seasons, higher dose oseltamivir compared to standard dose produced no additional benefits in patients with influenza A infection. It did lead to improved virologic response in those with influenza B, but this did not reach statistical significance. -
Does the AV Block Get Worse?
-
Fidaxomicin More Effective than Vancomycin for Clostridium difficile Infection in Cancer Patients?
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.